Analysis of metallothionein and vimentin immunoreactivity in pharyngeal squamous cell carcinoma and its microenvironment

The Analysis of Receptor-binding Cancer Antigen Expressed on SiSo Cells (RCAS1) immunoreactivity within the microenvironment of the ovarian cancer lesion relative to the applied therapeutic strategy

(2011) Wojciech Jozwicki et al.   CELL AND TISSUE RESEARCH

Vimentin in cancer and its potential as a molecular target for cancer therapy

(2011) Arun Satelli et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer

(2010) T. OKADA et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Increase in the proportion of granulated CD56+ T cells in patients with malignancy

(2010) Y. TAKII et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

The possible biological role of metallothionein in apoptosis

(2008) Magdalena Dutsch-Wicherek   Frontiers in Bioscience-Landmark

The tumor microenvironment and its contribution to tumor evolution toward metastasis

(2008) Girieca Lorusso et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility

(2008) R. J. Paccione et al.   MOLECULAR CANCER THERAPEUTICS